Medical Information on Counterbalance of Zika infection

Journal of Health & Medical Informatics

ISSN: 2157-7420

Open Access

Opinion - (2023) Volume 14, Issue 2

Medical Information on Counterbalance of Zika infection

Senait Aseffa*
*Correspondence: Senait Aseffa, Department of Pathology, Addis Ababa University, Addis Ababa 70710, Ethiopia, Email:
Department of Pathology, Addis Ababa University, Addis Ababa 70710, Ethiopia

Received: 02-Feb-2023, Manuscript No. jhmi-23-91203; Editor assigned: 04-Feb-2023, Pre QC No. P-91203; Reviewed: 16-Feb-2023, QC No. Q-91203; Revised: 21-Feb-2023, Manuscript No. R-91203; Published: 28-Feb-2023 , DOI: 10.37421/2157-7420.2023.14.462
Citation: Aseffa, Senait. “Medical Information on Counterbalance of Zika Infection.” J Health Med Informat 14 (2023): 462.
Copyright: © 2023 Aseffa S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Recurrent outbreaks of the Zika virus are evidence that it may be to blame for conditions like congenital Zika virus syndrome. It's still hard to make therapeutic interventions that work. Although antibody-dependent enhancement reactions can cause the antibody response to fail, antibodies can provide widespread protection. A crucial step in the process of producing fine neutralizing antibodies is selecting the target antigen. Phage display technology was used to select human anti-Zika virus antibodies. The antibodies were chosen to target a mimetic peptide based on the Zika virus's extremely conserved fusion loop location in protein E, which is found in all other flaviviruses.

Using the artificial peptide, four rounds of determination were carried out in two ways: The first involved removing specific phages through acidic elution, and the second involved using a different method. Combining methods from NGS and bioinformatics was used to select the VH and VL domains after panning. Three unique human monoclonal antibodies had been expressed as scFvs and characterized in a similar manner. All of them demonstrated cross-recognition with the yellow fever (YFV) and dengue (DENV) viruses as well as a binding capability to Zika (ZIKV). In vitro, the ZIKV contamination ought to be neutralized by two of these antibodies, AZ1p and AZ6m. These new antibodies have the potential to be used as therapeutic interventions against Zika virus and other flavivirus diseases due to the conservation of the fusion loop region.


Flavivirus infections, which are similar to the Zika virus and cause illness and death to millions of people each time, are a global health issue that has significant social and economic repercussions in a variety of nations, particularly in the Americas, Africa, some European nations, and Asia. Additionally, non-endemic regions are in danger due to climate change and the transmission route, which could result in outbreaks. This process is complicated by the resistance that these infections have developed, such as the ADE (antibody-dependent improvement) miracle or the development of mutations that provide immunological escape. Curatives and vaccines are less likely to be successful when these factors are taken together [1-5].

Because of associated neurological impairments like the Guillain-Barré pattern, meningoencephalitis, and natural deformations, as well as the contagion's capacity to infect neuronal ancestor cells, outbreaks of the Zika virus pose new challenges for conventions. The purported normal Zika disease design (CZS) has come a famous object of disquisition. The encephalon, supplementary nervous system of fetuses, and cadaverous muscular system can all be affected. A positive-sense single-stranded RNA patch is the inheritable material of the Zika contagion arbovirus.

The ultimate are involved in the assembly, inhibition, and replication of the contagion as well as the vulnerable response's inhibition. The N-terminal portion of Protein E, sphere I, which influences viral tropism, is made up of three disciplines. sphere II, which includes the emulsion circle and the dimerization region; and sphere III, which functions as a list for membrane receptors. Among flaviviruses, the emulsion circle (FL) is the most conserved E protein region and is involved in the infection process. Relationships with specific entry receptors and attachment factors on the cell surface initiate the viral cycle. Additionally, clathrinmediated endocytosis accounts for the majority of the viral flyspeck's cell entry. The viral envelope undergoes conformational changes in the late endosome due to the low pH terrain, which results in the insertion of the emulsion circle into the endosome membrane.


The energy delivered by the trade intermediated by FL and the envelope's primary change advances the emulsion severance's adaptation, considering the viral genome's delivery into the cytoplasm. An effective treatment option for viral infections is immunotherapy with monoclonal antibodies. These motes have the ability to increase antigenic donation and cellular vulnerable responses while also blocking the viral infection cycle at various stages. Effective negative antibodies and a safe deposit box are reasons to get vaccinated against emerging diseases and immuno compromised individuals. Then, mortal anti-ZIKV antibodies have been reported. Due to their ability to bind to a ZIKV emulsion circle-deduced peptide, they were given their names from a naive phage displayed library. To describe negative and list conditioning, the named VH and VL disciplines were combined and expressed as scFv. The findings indicate that these antibodies have a negative effect on the Zika virusWe reported on two new negativing recombinant antibodies, AZ1p and AZ6m, insulated from anon-immune phage display library. Their particularity and negativing parcels support the use of a naive antibody force to yield technologically applicable biomolecules.


  1. Nunez-Castilla, Janelle, Jordon Rahaman, Joseph B. Ahrens and Christian A. Balbin, et al. "Exploring evolutionary constraints in the proteomes of Zika, Dengue, and other Flaviviruses to find fitness-critical sites." J Mol Evol 88 (2020): 399-414.
  2. Google Scholar, Crossref, Indexed at 

  3. Hughes, Brandon W., Krishna C. Addanki, Ahila N. Sriskanda and Ewen McLean, et al. "Infectivity of immature neurons to Zika virus: A link to congenital Zika syndrome." EBioMedicine 10 (2016): 65-70.
  4. Google Scholar, Crossref, Indexed at 

  5. Stettler, Karin, Martina Beltramello, Diego A. Espinosa and Victoria Graham, et al. "Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection." Science 353 6301 (2016): 823-826.
  6. Google Scholar, Crossref, Indexed at 

  7. Saiz, Juan-Carlos, Nereida Jiménez de Oya and Miguel A. Martín-Acebes. "Host-directed antivirals: A realistic alternative to fight Zika virus." Viruses 10 (2018): 453.
  8. Google Scholar, Crossref, Indexed at 

  9. Murin, Charles D., Ian A. Wilson and Andrew B. Ward. "Antibody responses to viral infections: A structural perspective across three different enveloped viruses." Nat Microbiol 4 (2019): 734-747.
  10. Google Scholar, Crossref, Indexed at 

Google Scholar citation report
Citations: 2128

Journal of Health & Medical Informatics received 2128 citations as per Google Scholar report

Journal of Health & Medical Informatics peer review process verified at publons

Indexed In

arrow_upward arrow_upward